Product Manual

BD HD Check system:
a revolution in hazardous
drug detection
Speak to your BD representative
or visit bd.com/HDCheck to learn more.
References: 1. Cavallo D, Ursini CL, Perniconi B, et al. Evaluation of genotoxic eects induced by exposure to
antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy
employees.
Mutat Res . 2005;587(1-2):45-51. 2. McDiarmid MA, Oliver MS, Roth TS, Rogers B, Escalante C.
Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs.
J Occup Environ
Med . 2010;52(10):1028-1034. 3. Skov T, Maarup B, Olsen J, Rørth M, Winthereik H, Lynge E. Leukaemia
and reproductive outcome among nurses handling antineoplastic drugs.
Br J Ind Med . 1992;49(12):
855-861. 4. Hansen J, Olsen JH. Cancer morbidity among Danish female pharmacy technicians.
Scand
J Work Environ Health
. 1994;20(1):22-26. 5. Lawson CC, Rocheleau CM, Whelan EA, et al. Occupational
exposures among nurses and risk of spontaneous abortion.
Am J Obstet Gynecol . 2012;206(4):327.e1-8.
6. Hemminki K, Kyronen P, Lindbohm ML. Spontaneous abortions and malformations in the ospring of
nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on
registered information of outcome.
J Epidemiol Community Health . 1985;39(2):141-147.
7. Sotaniemi EA, Sutinen S, Arranto AJ, et al. Liver damage in nurses handling cytostatic agents.
Acta Med Scand . 1983;214(3):181-189. 8. Kimeyer TK, Tuerk J, Hahn M, et al. Application and
assessment of regular environmental monitoring of the antineoplastic drug contamination level in
pharmacies–the MEWIP project.
Ann Occup Hyg . 2013;57(4):444-455. 9. Connor TH, Massoomi F.
Environmental monitoring and medical surveillance of health care workers who handle hazardous
drugs (HDs). In: Mansur J, ed.
Improving Safe Handling Practices for Hazardous Drugs . Oak Brook, IL:
Joint Commission Resources; 2016:139-167. 10. Connor TH, Zock MD, Snow AH. Surface wipe sampling
for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings:
methodology and recommendations.
J Occup Environ Hyg . 2016;13(9):658-667. 11. Connor TH,
McDiarmid MA. Preventing occupational exposures to antineoplastic drugs in healthcare settings.
CA Cancer J Clin . 2006;56(6):354-365. 12. Connor TH, Smith JP. New approaches to wipe sampling
methods for antineoplastic and other hazardous drugs in healthcare settings.
Pharm Technol Hosp
Pharm . 2016;1(3):107-114. 13. The United States Pharmacopeial Convention. USP 39–NF 34
Physical tests: <800> Hazardous drugs handling in healthcare settings. Chapter to become ocial
December 2019.
bd.com
BD and the BD Logo are trademarks of Becton, Dickinson and Company.
© 2019 BD and its subsidiaries. All rights reserved. BD-5569 (1/19)
 Current guidelines and standards recommend routine
monitoring to help improve environmental quality
and control.
 The BD HD Check system detects select hazardous drugs
in less than 10 minutes to help facilitate routine monitoring
and evaluate your institution’s safe handling practices.
Order today—together let’s keep a check
on surface contamination
BD, Franklin Lakes, NJ, 07417, U.S.
Part no. Product Case
515020 Analyzer 1
515033 Collection kit 20
515024 Surface area templates 20
515025 Doxorubicin assay cartridges 20
515026 Doxorubicin assay cartridges 40
515029 Methotrexate assay cartridges 20
515030 Methotrexate assay cartridges 40
515031 Cyclophosphamide assay cartridges 20
515032 Cyclophosphamide assay cartridges 40